Milton H. Werner - 01 Mar 2023 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Milton H. Werner
Issuer symbol
IKT
Transactions as of
01 Mar 2023
Net transactions value
$0
Form type
4
Filing time
03 Mar 2023, 16:00:33 UTC
Previous filing
16 Aug 2022
Next filing
03 Apr 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKT Stock Option (right to buy) Award $0 +210,000 $0.000000 210,000 01 Mar 2023 Common Stock 210,000 $0.7400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the options will vest and become exercisable on 3/1/2024, and the remaining portion will vest and become exercisable in 24 equal monthly installments commencing on the first day of April 2024, subject to continued employment through each such vesting date.